B Dekel

Summary

Country: Israel

Publications

  1. ncbi request reprint Organ-injury-induced reactivation of hemangioblastic precursor cells
    B Dekel
    Department of Pediatrics and Laboratory of Regenerative Nephrology, Edmond and Lili Safra Children s Hospital, Sheba Medical Center, Tel Hashomer, Israel
    Leukemia 22:103-13. 2008
  2. doi request reprint Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target
    N Pode-Shakked
    Pediatric Stem Cell Research Institute, Safra Children s Hospital and Sheba Center for Regenerative Medicine, Sheba Medical Center, Tel Hashomer, Israel
    Oncogene 30:1664-80. 2011

Collaborators

  • N Pode-Shakked
  • S Metsuyanim
  • M Mark-Danieli
  • E Buzhor
  • J Jacob-Hirsch
  • D Omer
  • Y Haberman-Ziv
  • O Harari-Steinberg
  • E Rom-Gross
  • R S Goldstein
  • S Bahar

Detail Information

Publications2

  1. ncbi request reprint Organ-injury-induced reactivation of hemangioblastic precursor cells
    B Dekel
    Department of Pediatrics and Laboratory of Regenerative Nephrology, Edmond and Lili Safra Children s Hospital, Sheba Medical Center, Tel Hashomer, Israel
    Leukemia 22:103-13. 2008
    ..Our results suggest organ-injury-induced reactivation of bone marrow-derived hemangioblasts and possible local angioblastic progenitors expressing SCL and SCL 3'En...
  2. doi request reprint Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target
    N Pode-Shakked
    Pediatric Stem Cell Research Institute, Safra Children s Hospital and Sheba Center for Regenerative Medicine, Sheba Medical Center, Tel Hashomer, Israel
    Oncogene 30:1664-80. 2011
    ..FZD7 Ab therapy alone or in combination with Wnt pathway antagonists may have a significant role in the treatment of WT via targeting of a tumor progenitor population...